Dawn Graham Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dawn Graham.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dawn Graham. Dawn Graham is Director in MEDIVATION, INC. ($MDVN) and Director in ENDOCYTE INC ($ECYT) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Xenon Pharmaceuticals Inc. ($XENE) and Director in Adverum Biotechnologies, Inc. ($ADVM) and Director in Global Blood Therapeutics, Inc. ($GBT).
Latest Insider Trading Transactions of Dawn Graham
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, ECYT, GBT, MDVN, PTCT, XENE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2021 | ADVM | Adverum Biotechnol ... | Svoronos Dawn | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
Apr 01 2021 | ADVM | Adverum Biotechnol ... | Svoronos Dawn | Director | Buy | P | 10.02 | 20,000 | 200,338 | 20,000 | 0 to 20 K |
Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Grant | A | 0.00 | 1,650 | 0 | 27,936 | 26.3 K to 27.9 K (+6.28 %) |
Dec 11 2020 | ADVM | Adverum Biotechnol ... | Svoronos Dawn | Director | Option Exercise | A | 12.82 | 45,000 | 576,900 | 45,000 | |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | A | 0.00 | 3,037 | 0 | 3,037 | |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | A | 0.00 | 3,037 | 0 | 3,037 | |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | A | 64.75 | 5,247 | 339,743 | 5,247 | |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | A | 64.75 | 5,247 | 339,743 | 5,247 | |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | M | 0.00 | 4,800 | 0 | 0 | |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | M | 0.00 | 4,800 | 0 | 0 | |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Sell | S | 64.42 | 881 | 56,750 | 2,256 | 3.1 K to 2.3 K (-28.08 %) |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Sell | S | 64.42 | 881 | 56,750 | 2,256 | 3.1 K to 2.3 K (-28.08 %) |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Sell | S | 63.69 | 1,663 | 105,913 | 3,137 | 4.8 K to 3.1 K (-34.65 %) |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Sell | S | 63.69 | 1,663 | 105,913 | 3,137 | 4.8 K to 3.1 K (-34.65 %) |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Buy | M | 0.00 | 4,800 | 0 | 4,800 | 0 to 4.8 K |
Jun 19 2020 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Buy | M | 0.00 | 4,800 | 0 | 4,800 | 0 to 4.8 K |
Jun 12 2020 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Sell | S | 48.36 | 364 | 17,603 | 26,286 | 26.7 K to 26.3 K (-1.37 %) |
Jun 02 2020 | XENE | Xenon Pharmaceutic ... | Svoronos Dawn | Director | Option Exercise | A | 13.11 | 10,000 | 131,100 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Grant | A | 0.00 | 1,650 | 0 | 26,650 | 25 K to 26.7 K (+6.60 %) |
Sep 18 2019 | XENE | Xenon Pharmaceutic ... | Svoronos Dawn | Director | Option Exercise | A | 9.44 | 15,000 | 141,600 | 15,000 | |
Jun 20 2019 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | A | 0.00 | 4,800 | 0 | 4,800 | |
Jun 20 2019 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | A | 56.30 | 7,500 | 422,250 | 7,500 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Dec 21 2018 | GBT | Global Blood Thera ... | Svoronos Dawn | Director | Option Exercise | A | 38.68 | 30,000 | 1,160,400 | 30,000 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | Svoronos Dawn | Director | Option Exercise | D | 10.81 | 19,500 | 210,795 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | Svoronos Dawn | Director | Option Exercise | D | 10.81 | 22,500 | 243,225 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | Svoronos Dawn | Director | Sell | D | 24.00 | 3,300 | 79,200 | 0 | 3.3 K to 0 (-100.00 %) |
Dec 21 2018 | ECYT | ENDOCYTE INC | Svoronos Dawn | Director | Sell | D | 24.00 | 3,750 | 90,000 | 0 | 3.8 K to 0 (-100.00 %) |
Jun 05 2018 | XENE | Xenon Pharmaceutic ... | Svoronos Dawn | Director | Option Exercise | A | 6.20 | 15,000 | 93,000 | 15,000 | |
May 04 2018 | ECYT | ENDOCYTE INC | Svoronos Dawn | Director | Option Exercise | A | 10.81 | 42,000 | 454,020 | 42,000 | |
May 04 2018 | ECYT | ENDOCYTE INC | Svoronos Dawn | Director | Grant | A | 0.00 | 7,050 | 0 | 7,050 | 0 to 7.1 K |
Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 18.01 | 14,000 | 252,140 | 14,000 | |
Aug 15 2017 | XENE | Xenon Pharmaceutic ... | Svoronos Dawn | Director | Buy | P | 2.82 | 50,000 | 140,770 | 50,000 | 0 to 50 K |
Jun 02 2017 | XENE | Xenon Pharmaceutic ... | Svoronos Dawn | Director | Option Exercise | A | 3.85 | 3,500 | 13,475 | 3,500 | |
May 24 2017 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Buy | P | 13.49 | 25,000 | 337,230 | 25,000 | 0 to 25 K |
Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Option Exercise | D | 58.89 | 6,228 | 366,767 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Option Exercise | D | 55.45 | 6,284 | 348,448 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Option Exercise | D | 44.82 | 11,046 | 495,026 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Option Exercise | D | 38.89 | 9,584 | 372,686 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Option Exercise | D | 24.60 | 12,232 | 300,907 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Option Exercise | D | 26.36 | 30,000 | 790,650 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Sell | U | 0.00 | 21,206 | 0 | 0 | 21.2 K to 0 (-100.00 %) |
Sep 27 2016 | XENE | Xenon Pharmaceutic ... | Svoronos Dawn | Director | Option Exercise | A | 8.15 | 5,144 | 41,924 | 5,144 | |
Jun 23 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Option Exercise | A | 58.89 | 6,228 | 366,767 | 6,228 | |
Jun 23 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Grant | A | 0.00 | 2,972 | 0 | 21,206 | 18.2 K to 21.2 K (+16.30 %) |
Jun 13 2016 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 7.24 | 20,000 | 144,800 | 20,000 | |
Mar 16 2016 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Sell | S | 38.90 | 6,000 | 233,400 | 18,234 | 24.2 K to 18.2 K (-24.76 %) |
Sep 08 2015 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Sell | S | 89.15 | 3,100 | 276,365 | 12,117 | 15.2 K to 12.1 K (-20.37 %) |
Jun 18 2015 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Option Exercise | A | 110.90 | 3,142 | 348,448 | 3,142 | |
Jun 18 2015 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Grant | A | 0.00 | 1,578 | 0 | 15,217 | 13.6 K to 15.2 K (+11.57 %) |
Mar 04 2015 | MDVN | MEDIVATION, INC. | Svoronos Dawn | Director | Sell | S | 119.75 | 3,350 | 401,163 | 13,639 | 17 K to 13.6 K (-19.72 %) |
Jul 02 2013 | MDVN | MEDIVATION, INC. | Graham Dawn | Director | Option Exercise | A | 49.20 | 6,116 | 300,907 | 6,116 | |
Jul 02 2013 | MDVN | MEDIVATION, INC. | Graham Dawn | Director | Grant | A | 0.00 | 3,557 | 0 | 11,057 | 7.5 K to 11.1 K (+47.43 %) |
Apr 30 2013 | MDVN | MEDIVATION, INC. | Graham Dawn | Director | Option Exercise | A | 52.71 | 15,000 | 790,650 | 15,000 | |
Apr 23 2013 | MDVN | MEDIVATION, INC. | Graham Dawn | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 15 K to 7.5 K (-50.00 %) |
Page: 1